Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermot Cox

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Nature Reviews. Drug Discovery|October 2, 2010
Integrins as therapeutic targets: lessons and opportunitiesDermot Cox, Marian Brennan, Niamh Moran
Nature Reviews. Microbiology|May 20, 2006
The interaction of bacterial pathogens with plateletsJ Ross Fitzgerald, Timothy J Foster, Dermot Cox
Plos Neglected Tropical Diseases|June 13, 2014
The role of platelets in the pathogenesis of viral hemorrhagic feversJuan C Zapata, Dermot Cox, Maria S Salvato
Current Cardiology Reports|June 1, 2023
Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and ThrombosisJonathan Shpigelman, Anastasia Proshkina, Michael J Daly, et al.
Pediatric Cardiology|May 16, 2024
The Effects of Aspirin dose in Children with Congenital and Acquired Heart Disease. Results from the Paediatric Study of Aspirin Efficacy using Diagnostic and Monitoring Tools (PAED-M)Irene E Regan, Dermot Cox, Sean T Kelleher, et al.
Frontiers in Immunology|August 27, 2019
Early Host Interactions That Drive the Dysregulated Response in SepsisSteven W Kerrigan, Tatyana Devine, Glenn Fitzpatrick, et al.
Cardiology in the Young|September 26, 2024
Efficacy and speed of effect after the first dose of aspirin in children with congenital heart diseaseIrene E Regan, Sean T Kelleher, Dermot Cox, et al.
Infection and Immunity|April 18, 2007
Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor BHelen Miajlovic, Anthony Loughman, Marian Brennan, et al.
Journal of the American College of Cardiology|February 21, 2004
Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitorDermot Kearney, Anthony Byrne, Peter Crean, et al.
Platelets|September 19, 2019
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patientsMeadhbh McCall, Aaron Peace, Anthony F Tedesco, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Nature Reviews. Drug Discovery|October 2, 2010
Integrins as therapeutic targets: lessons and opportunitiesDermot Cox, Marian Brennan, Niamh Moran
Nature Reviews. Microbiology|May 20, 2006
The interaction of bacterial pathogens with plateletsJ Ross Fitzgerald, Timothy J Foster, Dermot Cox
Plos Neglected Tropical Diseases|June 13, 2014
The role of platelets in the pathogenesis of viral hemorrhagic feversJuan C Zapata, Dermot Cox, Maria S Salvato
Current Cardiology Reports|June 1, 2023
Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and ThrombosisJonathan Shpigelman, Anastasia Proshkina, Michael J Daly, et al.
Pediatric Cardiology|May 16, 2024
The Effects of Aspirin dose in Children with Congenital and Acquired Heart Disease. Results from the Paediatric Study of Aspirin Efficacy using Diagnostic and Monitoring Tools (PAED-M)Irene E Regan, Dermot Cox, Sean T Kelleher, et al.
Frontiers in Immunology|August 27, 2019
Early Host Interactions That Drive the Dysregulated Response in SepsisSteven W Kerrigan, Tatyana Devine, Glenn Fitzpatrick, et al.
Cardiology in the Young|September 26, 2024
Efficacy and speed of effect after the first dose of aspirin in children with congenital heart diseaseIrene E Regan, Sean T Kelleher, Dermot Cox, et al.
Infection and Immunity|April 18, 2007
Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor BHelen Miajlovic, Anthony Loughman, Marian Brennan, et al.
Journal of the American College of Cardiology|February 21, 2004
Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitorDermot Kearney, Anthony Byrne, Peter Crean, et al.
Platelets|September 19, 2019
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patientsMeadhbh McCall, Aaron Peace, Anthony F Tedesco, et al.
Pageof 5